Haviland Kate

Blueprint Medicines Corp

CHIEF EXECUTIVE OFFICER

Avg. Two Year Performance

No Purchase Track Record

(11%) Avg. Sale Return (5%) Compound

Holdings: 153.18K shares

Last Three Months: 05-Feb-24 -- 04-May-24

($1.13M) Net Amount

Buy:	0	--
Sell:	($1.13M)	$90.69

Sentiment

Insider Trading Sentiment: Accumulate

Company Sentiment

Biotechnology

Drugs

Two Year Chart

05-May-22 -- 04-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions